Skip to main content
Clinical Trials/CTRI/2021/09/036188
CTRI/2021/09/036188
Active, not recruiting
Phase 1

Effectiveness of autologous platelet rich plasma for the treatment of pressure ulcers in people with spinal cord injury: a randomized controlled trial.

Indian Council of Medical Research0 sites0 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Health Condition 1: null- Spinal cord injured
Sponsor
Indian Council of Medical Research
Status
Active, not recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Participants with age more than 18 and less than 65 years.
  • 2\. Participants or close relative must be able to give voluntary written consent.
  • 3\. Participants with sacral PU with \<3m duration.
  • 4\. Pressure ulcer of grade III \& IV will be included in the study.
  • 5\. Participant who hospitalized for rehabilitation at ISIC will be included in the study.

Exclusion Criteria

  • 1\. Mental, psychiatric or cognitive disorder and /or pre\-existing medical condition that might interfere with the outcomes.
  • 2\. Pressure sores associated with osteomyelitis, malignancy, leprosy and HIV (\+ve)
  • 3\. Platelet dysfunction
  • 4\. Arterial origin of the cutaneous ulcers.
  • 5\. Active vasculitis,
  • 6\. Systemic lupus erythematosus, cryoglobulinemia,
  • 7\. Hematological abnormality or any coagulation abnormalities.
  • 8\. Current use of anticoagulants and/or treatment with immunosuppressant drugs;
  • 9\. Serum hemoglobin concentration \<11 g/dL or hematocrit \<34%;
  • 10\. Participant taking drug which might interfere with the study intervention like Anti\- neoplastic drugs, steroids, antibiotics etc.

Outcomes

Primary Outcomes

Not specified

Similar Trials